Loading...

PEROXISOMAL DISORDER GENE PANEL BY NGS, EDTA BLOOD

image not found

 NABL Cap Accredited 

The Peroxisomal Disorder Gene Panel by NGS is a comprehensive genetic test designed to identify mutations associated with peroxisomal biogenesis and single-enzyme defects. Metropolis Healthcare uses advanced Next-Generation Sequencing (NGS) to analyze multiple genes involved in peroxisome function and metabolic pathways. This test supports early diagnosis of complex metabolic disorders presenting with neurological, hepatic, or developmental symptoms. It is especially valuable for infants and children with suspected peroxisomal disorders or a relevant family history.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 21,000.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes:G0238

Frequently Asked Questions (FAQ's):

What does the Peroxisomal Disorder Gene Panel include?
It includes extensive gene sequencing performed by Metropolis Healthcare to detect mutations affecting peroxisome formation and metabolic activity.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses high-accuracy NGS platforms to sequence multiple metabolism-related genes from an EDTA blood sample.

Who should take this test?
Infants, children, or adults with developmental delays, seizures, liver dysfunction, or suspected metabolic disorders may benefit.

Can this test confirm a peroxisomal disorder?
Yes, it helps identify specific genetic defects that confirm various peroxisomal biogenesis and enzyme-related disorders.

What sample is required for this test?
An EDTA blood sample is required to extract DNA for detailed genetic sequencing.

Is this test useful for family counseling?
Yes, identifying the genetic mutation helps determine inheritance patterns and assess recurrence risks in families.

How long does Metropolis Healthcare take to provide results?
Results typically take a few weeks due to complex sequencing and expert interpretation.

Does this test help guide clinical management?

Yes, genetic confirmation supports early intervention, monitoring, and personalized care planning for affected individuals 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab